Interim Management Statement
16 May 2013
Source BioScience today publishes its Interim Management Statement for the year to date.
May 17th 2013
Source BioScience announces that its 2013 Annual General Meeting will be held at the Company's registered offices at 10.30 am on 12 June 2013.
16 May 2013
Source BioScience today publishes its Interim Management Statement for the year to date.
30 Apr 2013
Source BioScience today announces the acquisition of the entire issued share capital of Inverclyde Biologicals Limited, Motherwell, Scotland for a total consideration of £1.6 million payable in cash.
21 Mar 2013
Source BioScience, the European leader in DNA sequencing and genomic services, has launched a new range of life science research products branded reSource.
19 Mar 2013
The Board of Source BioScience plc today announces its unaudited results for the year ended 31 December 2012.
18 Mar 2013
The attached TR1 notification relates to Henderson Global Investors' shareholding in Source BioScience, which now stands at 12,076,025 shares, representing 5.89% of the Company's ordinary share capital
18 Mar 2013
The attached TR1 notification relates to Miton Group plc's shareholding in Source BioScience, which now stands at 13,816,376 shares, representing 6.75% of the Company's ordinary share capital
Get in touch for more information:
Find out more about our investors and about becoming an investor
